Clinical-stage biopharmaceutical company developing next-generation oral and injectable medicines for obesity and metabolic diseases using GLP-1 and other mechanisms.
Create a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.